Alpha 1 Biomedicals, SciClone deal

The companies began negotiating a deal under which SCLN (San Mateo, Calif.) would gain worldwide rights to Thymosin alpha 1 in exchange for an undisclosed amount of SCLN common stock. If completed, th...